is isn an aquistion target at this level?, page-35

quicksilva,
"but the real question for me is, is it good enough to disrupt Asthma sufferers current preventative measures and treatments?"

"A product like this would need to deeply penetrate the market both here in Australia and in America to really make some decent money"

if the answer to the first question was an unequivical yes, and if it was beyond reasonable doubt that it would penetrate the ultimate market size, ISN would be worth $30.00.
My bet is that it will go far and possibly even achieve these goals.
As soon as the market starts to feel this may be possible you may not be able to enter below $3.00. There is a ten bagger till then. Allmy opinion and do your own research.